Previous studies reported that MAP3K1, as a serine-threonine kinase of the MAPK family, is frequently mutated in breast cancer and further influences Th1 polarization, leading to an immune-desert phenotype in BC (62). The gene discussed is MARK2; the disease is breast cancer.